How is Mepolizumab Subcutaneous Route dosed?
For the treatment of severe asthma, mepolizumab subcutaneous route is typically given as an injection under the skin, usually on the upper arms, stomach, or thigh once every 4 weeks. The dosage for eosinophilic granulomatosis with polyangiitis (EGPA) and hypereosinophilic syndrome (HES) may vary, and the injection can be given every 4 weeks or every 6 weeks, depending on the specific treatment plan determined by your doctor. When used for chronic rhinosinusitis with nasal polyps (CRSwNP), mepolizumab may be given as an additional maintenance treatment, and the dosing schedule may vary depending on the patient's response to the medication. It is essential to follow your doctor's instructions and the patient information leaflet carefully for the appropriate dosing and usage of mepolizumab subcutaneous route.
What is the dosage form of Mepolizumab Subcutaneous Route?
Mepolizumab subcutaneous route is available in the following dosage forms:
- Solution
- Powder for Solution
How is Mepolizumab Subcutaneous Route administered?
Mepolizumab subcutaneous route is administered as a shot under the skin, usually on the upper arms, stomach, or thigh. It is usually given once every 4 weeks. The medicine may be given by a healthcare professional or self-administered at home after proper training and understanding of the injection process. Please read and follow the patient information leaflet carefully before using the medication.